Singapore is a hot spot of manufacturing ... Tuas Biomedical Park is home to 14 companies employing around 7,000 employees, with Amgen, GSK, Pfizer, Sanofi, MSD, Novartis, and Roche among AbbVie ...

at the heart of Singapore's life sciences hub. Tuas is home to upwards of 14 companies employing around 7,000 employees, with Amgen, GSK, Pfizer, AbbVie, MSD, Novartis, and Roche among Sanofi's ...

Q4 2024 Earnings Call Transcript March 5, 2025 Zymeworks Inc. misses on earnings expectations. Reported EPS is $-0.31 EPS, ...

The maiden Fortune India MNC 500 showcases India's largest multinationals, with a cumulative total income of ₹36.77 lakh cr ...

Justice Hellen Wasilwa said Pauline Wambui Gichuki was not granted an opportunity to be heard before her dismissal as a sales representative in 2018. An Employment and Labour Relations Court judge ...

The PMCPA has turned party pooper, coming down on GSK after learning that a U.K. employee celebrated a post about a prescription drug on LinkedIn. A panel of leaders at the PMCPA, pharma’s ...

44 percent say employers should support employee wellbeing. 24 percent say employers should support with eldercare or family care. 24 percent say employers should help employees save for ...

The market was pleased with the recent earnings report from GSK plc (LON:GSK), despite the profit numbers being soft. However, we think the company is showing some signs that things are more ...

Maybank Singapore is giving its junior employees a one-time payment of $1,250 in a bid to help them manage the rising costs of living. Employees eligible for the payout include those in Officer and ...

LONDON, - British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale back or abandon such goals in response to the U.S. president's ...

Salesforce plans to invest $1 billion in Singapore over the next five years as it seeks to fuel the adoption of its AI agent ...

Now, GSK is ready to play catch-up after nabbing its own FDA approval. The FDA approved the British drugmaker's Penmenvy vaccine to protect people ages 10 to 25 against meningococcal serogroups A ...